Over but not gone: lingering epigenetic effects of COVID-19

Area of Science:

• Immunology
• Epigenetics
• Molecular Biology

Background:

• Long COVID (post-COVID conditions) affects a significant portion of adults after SARS-CoV-2 infection.
• The underlying biological mechanisms driving Long COVID symptoms are not well understood.
• Immune system dysregulation is hypothesized to play a role in persistent symptoms.

Purpose of the Study:

• To investigate the long-term molecular and cellular changes in immune cells of patients after severe COVID-19.
• To identify potential epigenetic and transcriptional alterations contributing to Long COVID pathogenesis.
• To explore the impact of severe COVID-19 on myeloid lineage cells and their progenitors.

Main Methods:

• Analysis of epigenetic modifications (e.g., DNA methylation) in immune cells.
• Transcriptional profiling (RNA sequencing) to assess gene expression patterns.
• Comparative analysis between patients with a history of severe COVID-19 and healthy controls.
• Focus on myeloid cells and their progenitor populations.

Main Results:

• Significant and durable alterations in the epigenetic landscape of myeloid immune cells were observed in patients post-severe COVID-19.
• Distinct transcriptional signatures were identified in these myeloid cells, indicating long-term functional changes.
• These epigenetic and transcriptional changes were also present in myeloid progenitors, suggesting early-life programming effects.
• The findings point to a persistent immune cell dysfunction following severe SARS-CoV-2 infection.

Conclusions:

• Severe COVID-19 can induce lasting epigenetic and transcriptional reprogramming of myeloid immune cells and their progenitors.
• These durable cellular changes may contribute to the pathophysiology of Long COVID.
• Further research into targeting these immune cell alterations could offer therapeutic strategies for Long COVID.